Leading global vaccine products by market share 2017 and 2024

Prevnar 13, a pneumococcal vaccine developed by Pfizer and Daewoong, is projected to account for roughly 13 percent of the global vaccine market in 2024. While the product’s share would be considerably lower when compared to 2017, it is expected to remain the top vaccine product on the market.

The global vaccine market

Global vaccine revenue is expected to increase significantly for a number of pharmaceutical giants, such as GlaxoSmithKline, Merck & Co, Sanofi, and Pfizer. GSK’s vaccine-based revenue, for example, is forecast to grow by almost 40 percent between 2017 and 2024.

Sanofi vaccines

In 2018, Sanofi generated roughly close to 25 billion U.S. dollars through its pharmaceuticals segment, which is the company’s largest segment by far. Over five billion U.S. dollars were generated through the company’s vaccine division that year. Between 2016 and 2018, the company’s highest-yielding vaccines were for diseases, such as polio, pertussis, as well as influenza.

Top 5 global vaccine products by market share in 2017 and 2024

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

June 2018



Survey time period

as of May 2018

Supplementary notes

Statistic is ranked by 2024 market share based on revenues.
* Projected.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Sanofi"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.